{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T04:19:40Z","timestamp":1741925980530,"version":"3.38.0"},"reference-count":25,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Liver Journal"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:p> Background: Canada was the first country to approve elbasvir\/grazoprevir (EBR\/GZR) for the treatment of chronic HCV infection for genotypes 1 and 4 with or without ribavirin and genotype 3 with sofosbuvir, with no recommendation for baseline resistance testing. The aim of this study was to describe the effectiveness of EBR\/GZR and the profile of patients selected for treatment in a Canadian real-world setting. Methods: This multicenter retrospective study of HCV-infected patients treated with EBR\/GZR took place among selected Canadian health care providers, with no exclusion criteria. Primary outcome measures included parameters associated with patient profile and sustained virologic response at 12 weeks (SVR12) and 24 weeks after treatment. Results: A total of 408 patients were included; 244 had available SVR12 information (per-protocol population [PP]). Genotype distribution included 1a (54.7%), 1b (17.2%), 3\u00a0(11.8%), 4 (10.0%), and other (6.4%). The majority (88.7%) of participants were treated for 12 weeks without ribavirin. Fifty-nine (14.5%) participants, predominantly with genotype 1a (49\/59) infection, were tested for baseline resistance-associated substitutions (bRAS). SVR12 was achieved by 95.9% of the PP. In an exploratory analysis assessing potential predictors of SVR12, participants who had undergone bRAS testing (OR 0.14, 95% CI 0.03\u20130.64) and participants who had undergone liver transplant (OR 0.05, 95% CI 0.00\u20130.68) had significantly lower odds of achieving SVR12. Conclusions: This study supports the real-world effectiveness of EBR\/GZR\u2014including a broad range of genotypes and diverse fibrosis stages\u2014in the absence of bRAS testing and in special populations. <\/jats:p>","DOI":"10.3138\/canlivj-2019-0029","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T18:03:07Z","timestamp":1587578587000},"page":"251-262","source":"Crossref","is-referenced-by-count":0,"title":["The Z-Profile Study: a multicenter, retrospective cohort study to\u00a0assess the real-world use and effectiveness of elbasvir\/grazoprevir in Canadian adult patients with chronic hepatitis C"],"prefix":"10.3138","volume":"3","author":[{"given":"Edward","family":"Tam","sequence":"first","affiliation":[{"name":"LAIR Centre, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Tremblay","sequence":"additional","affiliation":[{"name":"Centre Sida Amiti\u00e9, Saint-J\u00e9r\u00f4me, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Fraser","sequence":"additional","affiliation":[{"name":"The Cool Aid Community Health Centre, Victoria, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Conway","sequence":"additional","affiliation":[{"name":"Vancouver Infectious Diseases Centre, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alnoor","family":"Ramji","sequence":"additional","affiliation":[{"name":"Gastroenterology Division, GI Research Institute (GIRI), Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Borgia","sequence":"additional","affiliation":[{"name":"William Osler Health System, Brampton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Tsoi","sequence":"additional","affiliation":[{"name":"St. Joseph\u2019s Healthcare Hamilton, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric M","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Vancouver General Hospital, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahe","family":"Rajendran","sequence":"additional","affiliation":[{"name":"The Peterborough Clinic, Peterborough, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisela","family":"Macphail","sequence":"additional","affiliation":[{"name":"Calgary Urban Project Society (CUPS), Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis","family":"Cooper","sequence":"additional","affiliation":[{"name":"The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyur","family":"Patel","sequence":"additional","affiliation":[{"name":"University Health Network, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Puglia","sequence":"additional","affiliation":[{"name":"Hamilton Health Sciences, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Trottier","sequence":"additional","affiliation":[{"name":"Clinique de M\u00e9decine Urbaine du Quartier Latin, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Deshaies","sequence":"additional","affiliation":[{"name":"CIUSSS Capitale Nationale, Quebec, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Doucette","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Ghali","sequence":"additional","affiliation":[{"name":"McGill University Health Center, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel\u00a0S","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi","family":"Halsey-Brandt","sequence":"additional","affiliation":[{"name":"Merck Canada Inc., Kirkland, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janie B","family":"Trepanier","sequence":"additional","affiliation":[{"name":"Merck Canada Inc., Kirkland, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1696","reference":[{"issue":"19","key":"r1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.14745\/ccdr.v40i19a02","volume":"40","author":"Trubnikov M YP","year":"2014","journal-title":"Can Commun Dis Rep."},{"key":"r2","unstructured":"2.CATIE. The epidemiology of hepatitis C in Canada. http:\/\/www.catie.ca\/en\/fact-sheets\/epidemiology\/epidemiology-hepatitis-c- canada (Accessed April 2018)."},{"issue":"3","key":"r3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4254\/wjh.v8.i3.139","volume":"8","author":"Zopf S","year":"2016","journal-title":"World J Hepatol"},{"issue":"4","key":"r4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1517\/14740338.2016.1157163","volume":"15","author":"Gamal N","year":"2016","journal-title":"Expert Opinion Drug Saf"},{"journal-title":"Expert Rev Gastroenterol Hepatol","author":"Flisiak R","key":"r5"},{"issue":"1","key":"r6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/1756283X16671293","volume":"10","author":"Vallet-Pichard A","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"issue":"6","key":"r7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/17474124.2017.1326817","volume":"11","author":"Jackson WE","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4","key":"r8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/14656566.2018.1444030","volume":"19","author":"Carrion AF","year":"2018","journal-title":"Expert Opin Pharmacother"},{"issue":"22","key":"r9","doi-asserted-by":"crossref","first-page":"E677","DOI":"10.1503\/cmaj.170453","volume":"190","author":"Shah H","year":"2018","journal-title":"CMAJ"},{"issue":"3","key":"r10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jhep.2015.04.009","volume":"63","author":"Forns X","year":"2015","journal-title":"J Hepatol"},{"issue":"8","key":"r11","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1016\/S2352-3018(15)00114-9","volume":"2","author":"Rockstroh JK","year":"2015","journal-title":"Lancet"},{"issue":"10003","key":"r12","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(15)00349-9","volume":"386","author":"Roth D","year":"2015","journal-title":"Lancet"},{"issue":"9973","key":"r13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(14)61793-1","volume":"385","author":"Sulkowski M","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"r14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M15-0785","volume":"163","author":"Zeuzem S","year":"2015","journal-title":"Ann Intern Med"},{"issue":"9973","key":"r15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(14)61795-5","volume":"385","author":"Lawitz E","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"r16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.gastro.2016.09.045","volume":"152","author":"Kwo P","year":"2017","journal-title":"Gastroenterology"},{"key":"r17","unstructured":"17.Merck Canada Inc. Product monograph including patient medication information: ZEPATIER\u00ae. Kirkland, Quebec: Merck Canada; 2017."},{"key":"r18","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/apt.14635","author":"Flamm SL","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"r19","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/jvh.12937","volume":"25","author":"Kramer JR","year":"2018","journal-title":"J Viral Hepatitis"},{"issue":"5","key":"r20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00535-018-1429-3","volume":"53","author":"Zeuzem S","year":"2018","journal-title":"J Gastroenterol"},{"issue":"6","key":"r21","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/hep.29852","volume":"67","author":"Foster GR","year":"2018","journal-title":"Hepatology"},{"key":"r22","unstructured":"22.Merck Sharp & Dohme Corp. ZEPATIER\u00ae US prescribing information. Whitehouse Station, NJ: Merck Sharp & Dohme Corp.; 2016\u20132018."},{"issue":"1","key":"r23","doi-asserted-by":"crossref","first-page":"S740","DOI":"10.1016\/S0168-8278(17)31973-6","volume":"66","author":"Flamm S","year":"2017","journal-title":"J Hepatol"},{"issue":"3","key":"r24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.24304\/kjcp.2017.27.3.150","volume":"27","author":"Min Gu Kang MJK","year":"2017","journal-title":"Korean J Clin Pharm"},{"issue":"9","key":"r25","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1046\/j.1365-2036.2002.01331.x","volume":"16","author":"Gaeta GB","year":"2002","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Canadian Liver Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/canlivj-2019-0029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T12:37:28Z","timestamp":1741869448000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/canlivj-2019-0029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.3138\/canlivj-2019-0029"],"URL":"https:\/\/doi.org\/10.3138\/canlivj-2019-0029","relation":{},"ISSN":["2561-4444","2561-4444"],"issn-type":[{"type":"print","value":"2561-4444"},{"type":"electronic","value":"2561-4444"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}